Log In
Print
BCIQ
Print
Print this Print this
 

Absorbica, Epuris (Cip-isotretinoin)

  Manage Alerts
Collapse Summary General Information
Company Cipher Pharmaceuticals Inc.
DescriptionOral semi-liquid capsule formulation of isotretinoin that uses the Lidose delivery system
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcne
Indication DetailsTreat severe recalcitrant nodular acne
Regulatory Designation

U.S. - Special Protocol Assessment (Treat severe recalcitrant nodular acne)

Partner

Ranbaxy Laboratories Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today